Classer les publications sur l'année
-
Pharmaco-Epidémiologie
Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France:the ENTRED study 2001
ROMON I, FOSSE S, ESCHWEGE E, SIMON D, WEILL A, VARROUD-VIAL M, DETOURNAY B, FAGOT-CAMPAGNA A
Diabetes Metab ; 34(2):140-147
-
Pharmaco-Epidémiologie
Mortalité des sujets épileptiques vivant en institution spécialisée en France
JALLON P, DE ZELICOURT M, CACHERA C, FAGNANI F, LAURENDEAU C
Epilepsies ; 2008;20(3):179-187
-
Ăconomie de la santĂ©
Modelling lifetimes cost consequences of RESTOR in cataract surgery in four European countries
LAFUMA A, BERDEAUX G
BMC Ophtalmol ; 8(1):12
-
Ăconomie de la santĂ©
La prise en charge mĂ©dicale et chirurgicale de l’obĂ©sitĂ© : le contexte mĂ©dico-Ă©conomique
DETOURNAY B
Technologie&Santé ; (66):19-22
-
Pharmaco-Epidémiologie
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study
DENIS P, LAFUMA A, JEANBAT V, LAURENDEAU C, BERDEAUX G
Clin Drug Investig ; 28(12):767-776
-
Pharmaco-Epidémiologie
Intermediate visual acuity without spectacles following bilateral ReSTORÂź implantation
CUQ C, SPERA C, LAURENDEAU C, LAFUMA A, BERDEAUX G
Eur J Ophtalmol ; 18(5):733-738
-
Pharmaco-Epidémiologie
Impact sur la fonction rĂ©nale d’un relais prĂ©coce de la formulation conventionnelle de l’amphotĂ©ricine B par sa formulation liposomale dans le cadre d’un traitement empirique antifongique (Etude Nephemat)
ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MONCHECOURT F, MAHI L, DERAY G
Med Mal Infect ; 38(4):208-214
-
Ăconomie de la santĂ©
Etude pharmaco-économique sur la prise en charge du reflux gastro-oesophagien en France en 2005 en médecine générale
MOULY S, CHARLEMAGNE A, LE JEUNNE PH, FAGNANI F
Presse Med ; 37:1397-1406
-
Pharmaco-Epidémiologie
Cutaneous Infrared Thermometry for Detecting Febrile Patients
HAUSFATER P, ZHAO Y, DEFRENNE S, BONNET P, RIOU B
Emerg Infect Dis ; 14(8):1255-1258
-
Ăconomie de la santĂ©
Costs and persistence of carbonic anhydrase inhibitor versus alpha2 agonists, associated with beta-blockers, in glaucoma an ocular hypertension : an analysis of the UKGPRD database
LAFUMA A, BERDEAUX G
Curr Med Res Opin ; 24(5):1519-1527
-
Ăconomie de la santĂ©
Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care : an analysis conducted on the UK General Practitioner Research Database
LAFUMA A, LAURENDEAU C, BERDEAUX G
J Med Econ ; 11(3):485-497
-
Ăconomie de la santĂ©
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by the United Kingdom General Practitioner Research Database
DENIS P, LAFUMA A, BERDEAUX G
Clin Ophtalmol ; 2(2):321-329
-
Ăconomie de la santĂ©
Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients : A French adaptation of CARDS
LAFUMA A, COLIN X, SOLESSE A
Arch Cardiovasc Dis ; 2008;101(5):327-332
-
Ăconomie de la santĂ©
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B
Appl Health Econ Health Policy ; 6(4):199-216
-
Ăconomie de la santĂ©
Aspects Ă©pidĂ©miologiques et Ă©conomiques de l’insulinothĂ©rapie en Fance mĂ©tropolitaine
DETOURNAY B
Med Mal Metab ; (2):149-152
  Â